Literature DB >> 15157411

Sleep, Sleep Apnea, and Epilepsy.

Carl W. Bazil1.   

Abstract

Sleep disorders occur commonly in patients with epilepsy, and can be responsible for symptoms of daytime somnolence and also can contribute to the intractability of epilepsy. The most important aspect of treating sleep disorders, especially sleep apnea, is the recognition of the problem. In a busy clinical practice, symptoms of sleep disorders are frequently overlooked or mistaken. Whenever sleep disruption or excessive daytime somnolence is potentially problematic, the patient should be referred to a sleep specialist and, if indicated, diagnostic testing performed (usually polysomnography with or without multiple sleep latency tests). The author also recommends that all patients receive basic counseling about sleep hygiene, because its principles are often helpful to patients in general. Even in the absence of a sleep disorder, the choice of an anticonvulsant can be partly tailored to the sleep needs of the patient, with alerting drugs (lamotrigine and felbamate) dosed early in the day and relatively sedating agents (phenobarbital and phenytoin) dosed later or at bedtime.

Entities:  

Year:  2004        PMID: 15157411     DOI: 10.1007/s11940-004-0033-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  26 in total

1.  Outpatient sleep recording during antiepileptic drug monotherapy.

Authors:  M E Drake; A Pakalnis; J E Bogner; J M Andrews
Journal:  Clin Electroencephalogr       Date:  1990-07

2.  Usefulness of polysomnography in epilepsy patients.

Authors:  B A Malow; G A Fromes; M S Aldrich
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

3.  Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.

Authors:  D Garcia-Borreguero; O Larrosa; Y de la Llave; K Verger; X Masramon; G Hernandez
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

4.  Effects of antiepileptic drugs on sleep architecture: a pilot study.

Authors:  Benjamin Legros; Carl W Bazil
Journal:  Sleep Med       Date:  2003-01       Impact factor: 3.492

5.  Effect of pramipexole in treatment of resistant restless legs syndrome.

Authors:  S C Lin; J Kaplan; C D Burger; P A Fredrickson
Journal:  Mayo Clin Proc       Date:  1998-06       Impact factor: 7.616

6.  Influence of therapeutic phenobarbital and phenytoin medication on the polygraphic sleep of patients with epilepsy.

Authors:  P Wolf; U U Röder-Wanner; M Brede
Journal:  Epilepsia       Date:  1984-08       Impact factor: 5.864

7.  Response of polygraphic sleep to phenytoin treatment for epilepsy. A longitudinal study of immediate, short- and long-term effects.

Authors:  U U Röder-Wanner; S Noachtar; P Wolf
Journal:  Acta Neurol Scand       Date:  1987-09       Impact factor: 3.209

8.  Treatment of the restless legs syndrome with carbamazepine: a double blind study.

Authors:  W Telstad; O Sørensen; S Larsen; P E Lillevold; P Stensrud; R Nyberg-Hansen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

9.  Gabapentin augments whole blood serotonin in healthy young men.

Authors:  M L Rao; P Clarenbach; M Vahlensieck; S Krätzschmar
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy.

Authors:  M C Salinsky; B S Oken; L M Binder
Journal:  Epilepsia       Date:  1996-02       Impact factor: 5.864

View more
  1 in total

Review 1.  The Bucherer-Bergs Multicomponent Synthesis of Hydantoins-Excellence in Simplicity.

Authors:  Martin Kalník; Peter Gabko; Maroš Bella; Miroslav Koóš
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.